Pharmaceuticals

Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Report 2018

  • QYR2504743
  • 107 Pages
  • March 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the Asia-Pacific LAMEA Oncology/Anti-cancer drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of LAMEA Oncology/Anti-cancer drugs for these regions, from 2013 to 2025 (forecast), including

China

Japan

South Korea

Taiwan

India

Southeast Asia

Australia

Asia-Pacific LAMEA Oncology/Anti-cancer drugs market competition by top manufacturers/players, with LAMEA Oncology/Anti-cancer drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Roche

Novartis

Celgene

Amgen

Johnson & Johnson

GlaxoSmithKline

Eli lilly & Co

Pfizer

Merck & Co.

Sanofi

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Chemotherapy

Targeted Therapy

Immunotherapy (Biologic Therapy)

Hormonal Therapy

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Report 2018

1 LAMEA Oncology/Anti-cancer drugs Overview

1.1 Product Overview and Scope of LAMEA Oncology/Anti-cancer drugs

1.2 Classification of LAMEA Oncology/Anti-cancer drugs by Product Category

1.2.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Size (Sales) Comparison by Types (2013-2025)

1.2.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Size (Sales) Market Share by Type (Product Category) in 2017

1.2.3 Blood Cancer

1.2.4 Breast Cancer

1.2.5 Gastrointestinal Cancer

1.2.6 Prostate Cancer

1.2.7 Others

1.3 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market by Application/End Users

1.3.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales (Volume) and Market Share Comparison by Applications (2013-2025)

1.3.2 Chemotherapy

1.3.3 Targeted Therapy

1.3.4 Immunotherapy (Biologic Therapy)

1.3.5 Hormonal Therapy

1.3.6 Others

1.4 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market by Region

1.4.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Size (Value) Comparison by Region (2013-2025)

1.4.2 China Status and Prospect (2013-2025)

1.4.3 Japan Status and Prospect (2013-2025)

1.4.4 South Korea Status and Prospect (2013-2025)

1.4.5 Taiwan Status and Prospect (2013-2025)

1.4.6 India Status and Prospect (2013-2025)

1.4.7 Southeast Asia Status and Prospect (2013-2025)

1.4.8 Australia Status and Prospect (2013-2025)

1.5 Asia-Pacific Market Size (Value and Volume) of LAMEA Oncology/Anti-cancer drugs (2013-2025)

1.5.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales and Growth Rate (2013-2025)

1.5.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate (2013-2025)

2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Competition by Players/Suppliers, Region, Type and Application

2.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Competition by Players/Suppliers

2.1.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share of Key Players/Suppliers (2013-2018)

2.1.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue and Share by Players/Suppliers (2013-2018)

2.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs (Volume and Value) by Type

2.2.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales and Market Share by Type (2013-2018)

2.2.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue and Market Share by Type (2013-2018)

2.3 Asia-Pacific LAMEA Oncology/Anti-cancer drugs (Volume) by Application

2.4 Asia-Pacific LAMEA Oncology/Anti-cancer drugs (Volume and Value) by Region

2.4.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales and Market Share by Region (2013-2018)

2.4.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue and Market Share by Region (2013-2018)

3 China LAMEA Oncology/Anti-cancer drugs (Volume, Value and Sales Price)

3.1 China LAMEA Oncology/Anti-cancer drugs Sales and Value (2013-2018)

3.1.1 China LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2013-2018)

3.1.2 China LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate (2013-2018)

3.1.3 China LAMEA Oncology/Anti-cancer drugs Sales Price Trend (2013-2018)

3.2 China LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Type

3.3 China LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Application

4 Japan LAMEA Oncology/Anti-cancer drugs (Volume, Value and Sales Price)

4.1 Japan LAMEA Oncology/Anti-cancer drugs Sales and Value (2013-2018)

4.1.1 Japan LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2013-2018)

4.1.2 Japan LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate (2013-2018)

4.1.3 Japan LAMEA Oncology/Anti-cancer drugs Sales Price Trend (2013-2018)

4.2 Japan LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Type

4.3 Japan LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Application

5 South Korea LAMEA Oncology/Anti-cancer drugs (Volume, Value and Sales Price)

5.1 South Korea LAMEA Oncology/Anti-cancer drugs Sales and Value (2013-2018)

5.1.1 South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2013-2018)

5.1.2 South Korea LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate (2013-2018)

5.1.3 South Korea LAMEA Oncology/Anti-cancer drugs Sales Price Trend (2013-2018)

5.2 South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Type

5.3 South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Application

6 Taiwan LAMEA Oncology/Anti-cancer drugs (Volume, Value and Sales Price)

6.1 Taiwan LAMEA Oncology/Anti-cancer drugs Sales and Value (2013-2018)

6.1.1 Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2013-2018)

6.1.2 Taiwan LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate (2013-2018)

6.1.3 Taiwan LAMEA Oncology/Anti-cancer drugs Sales Price Trend (2013-2018)

6.2 Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Type

6.3 Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Application

7 India LAMEA Oncology/Anti-cancer drugs (Volume, Value and Sales Price)

7.1 India LAMEA Oncology/Anti-cancer drugs Sales and Value (2013-2018)

7.1.1 India LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2013-2018)

7.1.2 India LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate (2013-2018)

7.1.3 India LAMEA Oncology/Anti-cancer drugs Sales Price Trend (2013-2018)

7.2 India LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Type

7.3 India LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Application

8 Southeast Asia LAMEA Oncology/Anti-cancer drugs (Volume, Value and Sales Price)

8.1 Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales and Value (2013-2018)

8.1.1 Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2013-2018)

8.1.2 Southeast Asia LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate (2013-2018)

8.1.3 Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Price Trend (2013-2018)

8.2 Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Type

8.3 Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Application

9 Australia LAMEA Oncology/Anti-cancer drugs (Volume, Value and Sales Price)

9.1 Australia LAMEA Oncology/Anti-cancer drugs Sales and Value (2013-2018)

9.1.1 Australia LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate (2013-2018)

9.1.2 Australia LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate (2013-2018)

9.1.3 Australia LAMEA Oncology/Anti-cancer drugs Sales Price Trend (2013-2018)

9.2 Australia LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Type

9.3 Australia LAMEA Oncology/Anti-cancer drugs Sales Volume and Market Share by Application

10 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Players/Suppliers Profiles and Sales Data

10.1 Roche

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.1.2.1 Product A

10.1.2.2 Product B

10.1.3 Roche LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.1.4 Main Business/Business Overview

10.2 Novartis

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.2.2.1 Product A

10.2.2.2 Product B

10.2.3 Novartis LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.2.4 Main Business/Business Overview

10.3 Celgene

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.3.2.1 Product A

10.3.2.2 Product B

10.3.3 Celgene LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.3.4 Main Business/Business Overview

10.4 Amgen

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.4.2.1 Product A

10.4.2.2 Product B

10.4.3 Amgen LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.4.4 Main Business/Business Overview

10.5 Johnson & Johnson

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.5.2.1 Product A

10.5.2.2 Product B

10.5.3 Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.5.4 Main Business/Business Overview

10.6 GlaxoSmithKline

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.6.2.1 Product A

10.6.2.2 Product B

10.6.3 GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.6.4 Main Business/Business Overview

10.7 Eli lilly & Co

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.7.2.1 Product A

10.7.2.2 Product B

10.7.3 Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.7.4 Main Business/Business Overview

10.8 Pfizer

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.8.2.1 Product A

10.8.2.2 Product B

10.8.3 Pfizer LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.8.4 Main Business/Business Overview

10.9 Merck & Co.

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.9.2.1 Product A

10.9.2.2 Product B

10.9.3 Merck & Co. LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.9.4 Main Business/Business Overview

10.10 Sanofi

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 LAMEA Oncology/Anti-cancer drugs Product Category, Application and Specification

10.10.2.1 Product A

10.10.2.2 Product B

10.10.3 Sanofi LAMEA Oncology/Anti-cancer drugs Sales, Revenue, Price and Gross Margin (2013-2018)

10.10.4 Main Business/Business Overview

11 LAMEA Oncology/Anti-cancer drugs Manufacturing Cost Analysis

11.1 LAMEA Oncology/Anti-cancer drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of LAMEA Oncology/Anti-cancer drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 LAMEA Oncology/Anti-cancer drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of LAMEA Oncology/Anti-cancer drugs Major Manufacturers in 2017

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Forecast (2018-2025)

15.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue and Price Forecast (2018-2025)

15.1.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate Forecast (2018-2025)

15.1.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate Forecast (2018-2025)

15.1.3 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Price and Trend Forecast (2018-2025)

15.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)

15.2.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume and Growth Rate Forecast by Region (2018-2025)

15.2.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue and Growth Rate Forecast by Region (2018-2025)

15.2.3 China LAMEA Oncology/Anti-cancer drugs Sales, Revenue and Growth Rate Forecast (2018-2025)

15.2.4 Japan LAMEA Oncology/Anti-cancer drugs Sales, Revenue and Growth Rate Forecast (2018-2025)

15.2.5 South Korea LAMEA Oncology/Anti-cancer drugs Sales, Revenue and Growth Rate Forecast (2018-2025)

15.2.6 Taiwan LAMEA Oncology/Anti-cancer drugs Sales, Revenue and Growth Rate Forecast (2018-2025)

15.2.7 India LAMEA Oncology/Anti-cancer drugs Sales, Revenue and Growth Rate Forecast (2018-2025)

15.2.8 Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales, Revenue and Growth Rate Forecast (2018-2025)

15.2.9 Australia LAMEA Oncology/Anti-cancer drugs Sales, Revenue and Growth Rate Forecast (2018-2025)

15.3 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales, Revenue and Price Forecast by Type (2018-2025)

15.3.1 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Forecast by Type (2018-2025)

15.3.2 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Forecast by Type (2018-2025)

15.3.3 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Price Forecast by Type (2018-2025)

15.4 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Forecast by Application (2018-2025)

16 Research Findings and Conclusion

17 Appendix

17.1 Methodology/Research Approach

17.1.1 Research Programs/Design

17.1.2 Market Size Estimation

17.1.3 Market Breakdown and Data Triangulation

17.2 Data Source

17.2.1 Secondary Sources

17.2.2 Primary Sources

17.3 Disclaimer

List of Tables and Figures

Figure Product Picture of LAMEA Oncology/Anti-cancer drugs

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Type (2013-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type (Product Category) in 2017

Figure Blood Cancer Product Picture

Figure Breast Cancer Product Picture

Figure Gastrointestinal Cancer Product Picture

Figure Prostate Cancer Product Picture

Figure Others Product Picture

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales (K Units) by Application (2013-2025)

Figure Asia-Pacific Sales Market Share of LAMEA Oncology/Anti-cancer drugs by Application in 2017

Figure Chemotherapy Examples

Table Key Downstream Customer in Chemotherapy

Figure Targeted Therapy Examples

Table Key Downstream Customer in Targeted Therapy

Figure Immunotherapy (Biologic Therapy) Examples

Table Key Downstream Customer in Immunotherapy (Biologic Therapy)

Figure Hormonal Therapy Examples

Table Key Downstream Customer in Hormonal Therapy

Figure Others Examples

Table Key Downstream Customer in Others

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Size (Million USD) by Region (2013-2025)

Figure China LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Japan LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure South Korea LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Taiwan LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure India LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Australia LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) and Growth Rate (2013-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Major Players Product Sales Volume (K Units)(2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales (K Units) of Key Players/Suppliers (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Share by Players/Suppliers (2013-2018)

Figure 2017 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Share by Players/Suppliers

Figure 2017 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Share by Players/Suppliers

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Market Major Players Product Revenue (Million USD) 2013-2018

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) by Players/Suppliers (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Share by Players

Figure 2017 Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Share by Players

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales and Market Share by Type (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Share by Type (2013-2018)

Figure Sales Market Share of LAMEA Oncology/Anti-cancer drugs by Type (2013-2018)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Growth Rate by Type (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Market Share by Type (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Share by Type (2013-2018)

Figure Revenue Market Share of LAMEA Oncology/Anti-cancer drugs by Type (2013-2018)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Growth Rate by Type (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) and Market Share by Region (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Share by Region (2013-2018)

Figure Sales Market Share of LAMEA Oncology/Anti-cancer drugs by Region (2013-2018)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Market Share by Region in 2017

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Market Share by Region (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Share (%) by Region (2013-2018)

Figure Revenue Market Share of LAMEA Oncology/Anti-cancer drugs by Region (2013-2018)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Market Share by Region in 2017

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) and Market Share by Application (2013-2018)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Share (%) by Application (2013-2018)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Market Share by Application (2013-2018)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Market Share by Application (2013-2018)

Figure China LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure China LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2018)

Figure China LAMEA Oncology/Anti-cancer drugs Sales Price (USD/Unit) Trend (2013-2018)

Table China LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Type (2013-2018)

Table China LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type (2013-2018)

Figure China LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type in 2017

Table China LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Applications (2013-2018)

Table China LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application (2013-2018)

Figure China LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application in 2017

Figure Japan LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Japan LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2018)

Figure Japan LAMEA Oncology/Anti-cancer drugs Sales Price (USD/Unit) Trend (2013-2018)

Table Japan LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Type (2013-2018)

Table Japan LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type (2013-2018)

Figure Japan LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type in 2017

Table Japan LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Applications (2013-2018)

Table Japan LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application (2013-2018)

Figure Japan LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application in 2017

Figure South Korea LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure South Korea LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2018)

Figure South Korea LAMEA Oncology/Anti-cancer drugs Sales Price (USD/Unit) Trend (2013-2018)

Table South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Type (2013-2018)

Table South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type (2013-2018)

Figure South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type in 2017

Table South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Applications (2013-2018)

Table South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application (2013-2018)

Figure South Korea LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application in 2017

Figure Taiwan LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Taiwan LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2018)

Figure Taiwan LAMEA Oncology/Anti-cancer drugs Sales Price (USD/Unit) Trend (2013-2018)

Table Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Type (2013-2018)

Table Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type (2013-2018)

Figure Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type in 2017

Table Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Applications (2013-2018)

Table Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application (2013-2018)

Figure Taiwan LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application in 2017

Figure India LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure India LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2018)

Figure India LAMEA Oncology/Anti-cancer drugs Sales Price (USD/Unit) Trend (2013-2018)

Table India LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Type (2013-2018)

Table India LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type (2013-2018)

Figure India LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type in 2017

Table India LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Application (2013-2018)

Table India LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application (2013-2018)

Figure India LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application in 2017

Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2018)

Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Price (USD/Unit) Trend (2013-2018)

Table Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Type (2013-2018)

Table Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type (2013-2018)

Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type in 2017

Table Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Applications (2013-2018)

Table Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application (2013-2018)

Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application in 2017

Figure Australia LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Australia LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate (2013-2018)

Figure Australia LAMEA Oncology/Anti-cancer drugs Sales Price (USD/Unit) Trend (2013-2018)

Table Australia LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Type (2013-2018)

Table Australia LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type (2013-2018)

Figure Australia LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Type in 2017

Table Australia LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) by Applications (2013-2018)

Table Australia LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application (2013-2018)

Figure Australia LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share by Application in 2017

Table Roche LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Roche LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Roche LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Roche LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Roche LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Novartis LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Novartis LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Novartis LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Novartis LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Novartis LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Celgene LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Celgene LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Celgene LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Celgene LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Celgene LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Amgen LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Amgen LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Amgen LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Amgen LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Amgen LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Johnson & Johnson LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Basic Information List

Table GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure GlaxoSmithKline LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Eli lilly & Co LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Pfizer LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Pfizer LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Pfizer LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Pfizer LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Pfizer LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Merck & Co. LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Merck & Co. LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Merck & Co. LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Merck & Co. LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Merck & Co. LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Sanofi LAMEA Oncology/Anti-cancer drugs Basic Information List

Table Sanofi LAMEA Oncology/Anti-cancer drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

Figure Sanofi LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate (2013-2018)

Figure Sanofi LAMEA Oncology/Anti-cancer drugs Sales Market Share in Asia-Pacific (2013-2018)

Figure Sanofi LAMEA Oncology/Anti-cancer drugs Revenue Market Share in Asia-Pacific (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price (USD/Unit) Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of LAMEA Oncology/Anti-cancer drugs

Figure Manufacturing Process Analysis of LAMEA Oncology/Anti-cancer drugs

Figure LAMEA Oncology/Anti-cancer drugs Industrial Chain Analysis

Table Raw Materials Sources of LAMEA Oncology/Anti-cancer drugs Major Manufacturers in 2017

Table Major Buyers of LAMEA Oncology/Anti-cancer drugs

Table Distributors/Traders List

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Price (USD/Unit) and Trend Forecast (2018-2025)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume (K Units) Forecast by Region (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share Forecast by Region (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Volume Market Share Forecast by Region in 2025

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) Forecast by Region (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Market Share Forecast by Region (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Market Share Forecast by Region in 2025

Figure China LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate Forecast (2018-2025)

Figure China LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Japan LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate Forecast (2018-2025)

Figure Japan LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure South Korea LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate Forecast (2018-2025)

Figure South Korea LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Taiwan LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate Forecast (2018-2025)

Figure Taiwan LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure India LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate Forecast (2018-2025)

Figure India LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate Forecast (2018-2025)

Figure Southeast Asia LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Australia LAMEA Oncology/Anti-cancer drugs Sales (K Units) and Growth Rate Forecast (2018-2025)

Figure Australia LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales (K Units) Forecast by Type (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Market Share Forecast by Type (2018-2025)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue (Million USD) Forecast by Type (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Revenue Market Share Forecast by Type (2018-2025)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Price (USD/Unit) Forecast by Type (2018-2025)

Table Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales (K Units) Forecast by Application (2018-2025)

Figure Asia-Pacific LAMEA Oncology/Anti-cancer drugs Sales Market Share Forecast by Application (2018-2025)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370